Verified Nov 2026
Other
·

Boston, Massachusetts
·
Since 1996
Paratek Pharmaceuticals is a Boston-based biopharmaceutical company founded in 1996 with 200–500 employees and revenue in the $100–250M band. It develops small-molecule therapies focused on infectious diseases and antimicrobial resistance, serving civilian, government, and military sectors. The company markets NUZYRA® for bacterial pneumonia and skin infections, and SEYSARA® for acne, and completed a combination with Radius Health in March 2026.
Paratek Pharmaceuticals at a glance
Revenue
$100-250M
Est. band
Employees
200-500
Founded
1996
Headquarters
Boston, Massachusetts
Industries
Automotive
Electric Vehicles
Medical
Military & Defense
Overview
Paratek Pharmaceuticals is a Boston-based biopharmaceutical company founded in 1996 with 200–500 employees and revenue in the $100–250M band. It develops small-molecule therapies focused on infectious diseases and antimicrobial resistance, serving civilian, government, and military sectors. The company markets NUZYRA® for bacterial pneumonia and skin infections, and SEYSARA® for acne, and completed a combination with Radius Health in March 2026.
At a glance
Attribute | Detail |
|---|---|
Founded | 1996 |
Headquarters | Boston, Massachusetts |
Employees | 200-500 |
Revenue | $100-250M (estimated) |
What Paratek Pharmaceuticals makes
Paratek specializes in tetracycline chemistry to create antimicrobial therapies targeting resistant pathogens and addressing public health threats.
Latest developments
2026-03-20 — Paratek Pharmaceuticals Combines With Radius Health | News & Rankings | About | Skadden, Arps, Slate, Meagher & Flom LLP (skadden.com)
2026-03-19 — Akin Advises Pharmakon in $100 Million Debt Financing for Paratek Pharmaceuticals and Radius Health Combination | Akin (akingump.com)
2026-03-18 — Paratek Pharmaceuticals Completes Combination with Radius Health, Expanding Its Multi-Product Specialty Commercial Platform | B-FLEXION (bflexion.com)
2026-03-18 — Blackstone Credit & Insurance Leads $1.3 Billion Financing to Support Combination of Paratek Pharmaceuticals and Radius Health - Blackstone (blackstone.com)
2026-02-24 — Paratek Pharmaceuticals Announces Positive Results for (globenewswire.com)
2026-02-24 — Paratek Pharmaceuticals Announces Positive Results for NUZYRA® Therapeutic Efficacy Studies in Inhalation Anthrax Triggering Additional Procurement under BARDA Project BioShield Contract | B-FLEXION (bflexion.com)
Company details
The company maintains offices in Boston, Massachusetts and King of Prussia, Pennsylvania, and is recognized as one of independent antibiotics companies globally. Paratek Pharmaceuticals was founded in 1996, has an estimated 200-500 employees, and is headquartered in Boston, Massachusetts.
Frequently asked questions
What does Paratek Pharmaceuticals do?
Paratek Pharmaceuticals is a Boston-based biopharmaceutical company founded in 1996 with 200–500 employees and revenue in the $100–250M band. It develops small-molecule therapies focused on infectious diseases and antimicrobial resistance, serving civilian, government, and military sectors. The company markets NUZYRA® for bacterial pneumonia and skin infections, and SEYSARA® for acne, and completed a combination with Radius Health in March 2026.
Where is Paratek Pharmaceuticals headquartered?
Paratek Pharmaceuticals is headquartered in Boston, Massachusetts (75 Park Plaza, Boston, Massachusetts, 02116).
When was Paratek Pharmaceuticals founded?
Paratek Pharmaceuticals was founded in 1996.
How big is Paratek Pharmaceuticals?
Paratek Pharmaceuticals has an estimated 200-500 employees, with revenue in the $100-250M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
